First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
13 févr. 2024 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma to Present at the DealFlow MicroCap Conference
23 janv. 2024 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
17 janv. 2024 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Respiratory Devices Market Size to be Worth USD 37.7 billion by 2031, with Notable CAGR of 6.1%| Transparency Market Research, Inc.
08 janv. 2024 08h44 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global respiratory devices market is estimated to flourish at a CAGR of 6.1% from 2023...
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines
13 nov. 2023 02h00 HE
|
ViaNautis Bio
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines ViaNautis’s proprietary drug delivery platform polyNaut® is designed to deliver...
Spexis Announces Changes to the Executive Committee
01 nov. 2023 02h20 HE
|
Spexis AG
Spexis Announces Changes to the Executive Committee
Spexis to host business update conference call on October 9, 2023
06 oct. 2023 01h30 HE
|
Spexis AG
Spexis to host business update conference call on October 9, 2023
Spexis provides business update and announces financial results for the first half of 2023
29 sept. 2023 01h30 HE
|
Spexis AG
Spexis provides business update and announces financial results for the first half of 2023
Cystic Fibrosis Market to Surpass USD 39.59 Billion by 2030 Driven by Growing Patient Population and Supportive Government Initiatives | Research by SNS Insider
20 sept. 2023 09h48 HE
|
SNS Insider pvt ltd
Pune, Sept. 20, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report indicates that in 2022, the Cystic Fibrosis Market was valued at USD 7.13 billion in 2022 & is projected to reach USD 39.59...
Vibrating Mesh Nebulizer Market Predicted to Reach USD 719.2 million by 2031, Expanding at a CAGR of 9.2%: TMR Report
15 sept. 2023 08h04 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global vibrating mesh nebulizer market is projected to flourish at a CAGR of 9.2% from...